KURT WHEELER
CIK 1252525 · last filed 2019-02-11
KURT WHEELER is a corporate insider who has filed 58 SEC Form 4 insider transactions across 14 companies since 2007. The most recent filing, for GMED, was dated Feb 11, 2019. Across all open-market trades the lifetime net is −$103.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.3M across reported positions. 152 SEC filings were submitted jointly with NICHOLAS GALAKATOS.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.30M
14
58
-$103.85M
Filer Profile
STE 410
SAN FRANCISCO, CA 94080
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GMED | Director | 44,319 | $74.57 | $3.30M | -$90.17M | 13 | 2019-02-11 |
| Radius Health, Inc. (RDUS) Delisted | 2,459,804 | $30.00 | $73.79M | $0 | 1 | 2016-09-29 | |
| Oxford Immunotec Global PLC (OXFD) Delisted | 10%+ Owner | 2,237,377 | — | — | -$8.32M | 2 | 2015-06-17 |
| Pernix Sleep, Inc. (SOMX) Delisted | Director | 475,951 | — | — | -$1.82M | 14 | 2012-07-02 |
| ZOGENIX, INC. (ZGNX) Delisted | Director | 747,805 | $26.68 | $19.95M | $7.00M | 4 | 2012-06-06 |
| ReShape Weightloss Inc. (ETRM) Delisted | 1,669,753 | — | — | $0 | 1 | 2010-12-15 | |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2010-10-04 |
| SENORX INC (SENO) Delisted | Director | 2,032,475 | — | — | -$2.77M | 6 | 2010-06-29 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 220,896 | $15.00 | $3.31M | $0 | 1 | 2010-03-18 | |
| Pharmasset Inc (VRUS) Delisted | 10%+ Owner | 16 | — | — | -$2.19M | 1 | 2008-02-11 |
| HEMOSENSE INC (HEM) Delisted | Director | 4,003,119 | — | — | -$6.07M | 3 | 2007-11-07 |
| CRYOCOR INC (CRYO) Delisted | Director | 3,028,082 | — | — | $496.3K | 2 | 2007-05-15 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | 3,846,328 | $1.95 | $7.50M | $0 | 1 | 2007-02-15 | |
| COTHERIX INC (CTRX) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2007-01-10 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-11 | GMED | Grant (A) | — | $0 | EDGAR |
| 2018-01-24 | GMED | Grant (A) | — | $0 | EDGAR |
| 2017-02-01 | GMED | Grant (A) | — | $0 | EDGAR |
| 2016-09-29 | Radius Health, Inc. (RDUS) Delisted | Other (J) | −3,689,706 | $0 | EDGAR |
| 2016-01-27 | GMED | Grant (A) | — | $0 | EDGAR |
| 2016-01-06 | GMED | Mixed | — | -$186.0K | EDGAR |
| 2015-06-17 | Oxford Immunotec Global PLC (OXFD) Delisted | Sell (S) | −329,840 | -$4.72M | EDGAR |
| 2015-06-12 | Oxford Immunotec Global PLC (OXFD) Delisted | Sell (S) | −252,784 | -$3.61M | EDGAR |
| 2015-01-22 | GMED | Grant (A) | — | $0 | EDGAR |
| 2014-01-27 | GMED | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.